Literature DB >> 1682163

Glutamic acid-112 of the A subunit of heat-labile enterotoxin from enterotoxigenic Escherichia coli is important for ADP-ribosyltransferase activity.

T Tsuji1, T Inoue, A Miyama, M Noda.   

Abstract

A mutant strain of enterotoxigenic Escherichia coli (E. coli pTUH 6A) produced an abnormal heat-labile enterotoxin (LT), the A subunit of which has a single amino acid substitution at position 112 (Glu-112 to Lys-112). As already reported, this mutant LT had no ileal loop and vascular permeability activities [(1990) J. Biol. Chem. 265, 22520-22525]. In this paper we report that the mutant LT showed no CHO cell elongation activity and did not activate adenylate cyclase of target cells. Moreover, no ADP-ribosyltransferase activity was detected in the mutant LT. It is concluded that the amino acid substitution at position 112 abolished the ADP-ribosyltransferase activity of the A subunit and this leads to the loss of toxic activities of LT.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682163     DOI: 10.1016/0014-5793(91)81311-u

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

Authors:  Frederik W van Ginkel; Raymond J Jackson; Naoto Yoshino; Yukari Hagiwara; Daniel J Metzger; Terry D Connell; Hong L Vu; Michael Martin; Kohtaro Fujihashi; Jerry R McGhee
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

2.  Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit.

Authors:  M R Fontana; R Manetti; V Giannelli; C Magagnoli; A Marchini; R Olivieri; M Domenighini; R Rappuoli; M Pizza
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

3.  Identification in traditional herbal medications and confirmation by synthesis of factors that inhibit cholera toxin-induced fluid accumulation.

Authors:  Hiroshi Oi; Daisuke Matsuura; Masami Miyake; Masamiti Ueno; Izumi Takai; Takeshi Yamamoto; Masayoshi Kubo; Joel Moss; Masatoshi Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

4.  Crystal structure of a non-toxic mutant of heat-labile enterotoxin, which is a potent mucosal adjuvant.

Authors:  F van den Akker; M Pizza; R Rappuoli; W G Hol
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

5.  ModA and ModB, two ADP-ribosyltransferases encoded by bacteriophage T4: catalytic properties and mutation analysis.

Authors:  Bernd Tiemann; Reinhard Depping; Egle Gineikiene; Laura Kaliniene; Rimas Nivinskas; Wolfgang Rüger
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

6.  Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

Authors:  C C Häse; L S Thai; M Boesman-Finkelstein; V L Mar; W N Burnette; H R Kaslow; L A Stevens; J Moss; R A Finkelstein
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  A classical strain of Vibrio cholerae with diminished ability to process the proteolytically sensitive site in the A subunit of cholera toxin.

Authors:  Y Ichinose; T Tsuji; M Kato; B C Neves; K Morita; M Ehara; T Hirayama
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

8.  Some properties of purified Escherichia coli heat-stable enterotoxin II.

Authors:  S Hitotsubashi; Y Fujii; H Yamanaka; K Okamoto
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal model.

Authors:  Asish Dasgupta; Sujata G Dastidar
Journal:  Indian J Med Res       Date:  2012-06       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.